Clinical trials
Carcinoma, Non-Small-Cell Lung trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
416 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 4 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 10 |
| 2009 | 11 |
| 2010 | 9 |
| 2011 | 10 |
| 2012 | 11 |
| 2013 | 7 |
| 2014 | 14 |
| 2015 | 30 |
| 2016 | 13 |
| 2017 | 19 |
| 2018 | 20 |
| 2019 | 26 |
| 2020 | 32 |
| 2021 | 36 |
| 2022 | 29 |
| 2023 | 27 |
| 2024 | 39 |
| 2025 | 34 |
| 2026 | 19 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 149 |
| Active, not recruiting | 109 |
| Recruiting | 86 |
| Terminated | 57 |
| Unknown status | 8 |
| Withdrawn | 2 |
| Not yet recruiting | 2 |
| No longer available | 1 |
| Enrolling by invitation | 1 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 53 |
| Novartis Pharmaceuticals | 38 |
| Pfizer | 33 |
| Merck Sharp & Dohme LLC | 29 |
| Eli Lilly and Company | 24 |
| Bristol-Myers Squibb | 23 |
| AbbVie | 19 |
| Hoffmann-La Roche | 18 |
| Boehringer Ingelheim | 12 |
| Daiichi Sankyo | 12 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 416 |
| Lung Neoplasms | 65 |
| Neoplasms | 46 |
| Neoplasm Metastasis | 34 |
| Colorectal Neoplasms | 29 |
| Melanoma | 25 |
| Squamous Cell Carcinoma of Head and Neck | 25 |
| Triple Negative Breast Neoplasms | 23 |
| Stomach Neoplasms | 22 |
| Ovarian Neoplasms | 21 |
Trials
Showing 76 to 100 of 416. Each trial links to its page on Pharma Observatory.
316 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.